Allotera Therapeutics
Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies
$35MSeries C
Role not disclosedLoading investors…
Activity from announced rounds
Develops allogeneic, off-the-shelf CAR-T cell therapies for hematological malignancies
Provides in-network psychiatric care using AI-powered technology
Pitching Banc of California? Send the deck from a free RoundOS data room and see which pages they read.
Create a free room